Plasma cell dyscrasias and amyloidosis

Otolaryngologic Clinics of North America

Volumn 36, Issue 4, 2003, Pages 747-764

  Lebowitz, Richard A ^a   Morris, Luc ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; COTRIMOXAZOLE; MELPHALAN; PENICILLIN V POTASSIUM; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

AMYLOIDOSIS; CANCER RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; ENDOSCOPIC SURGERY; FAMILIAL AMYLOIDOSIS; HUMAN; INFECTION PREVENTION; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PLASMA CELL DYSCRASIA; PLASMACYTOMA; REVIEW; STEM CELL TRANSPLANTATION;

EID: 0042804925     PISSN: 00306665     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0030-6665(03)00026-4     Document Type: Review

References (39)

1. Nofsinger YC, Mirza N, Rowan PT, et al. Head and neck manifestations of plasma cell neoplasms. Laryngoscope 1997;107(6):741-6.
2. Zundel RS, Pyle GM, Voytovich M. Head and neck manifestations of amyloidosis. Otolaryngol Head Neck Surg 1999;120(4):553-7.
3. Simpson GT, Strong MS, Skinner M, et al. Localized amyloidosis of the head and neck and upper aerodigestive and lower respiratory tracts. Ann Otol Rhinol Laryngol 1984;93: 374-378.
4. Longo DL. Plasma cell disorders. In: Braunwald E, Fauci A, editors. Harrison's principles of internal medicine. 15th edition. New York: McGraw Hill; 2001. p. 727-33.
5. Greipp PR. Plasma cell disorders. In: Humes HD, editor. Kelley's Textbook of internal medicine. 4th edition. Philadelphia: Lippincott, Williams, and Wilkins; 2000. p. 1700-7.
6. Riedel D, Ponern L. The epidemiology of multiple myeloma. Hematol Oncol Clin North Am 1992;6(2):225-47.
7. Mill W, Griffith R. The role of radiation therapy in the management of plasma cell tumors. Cancer 1980;45:647-52.
8. Creston JE. The otolaryngological manifestations of multiple myeloma. Laryngoscope 1978;88:1320-32.
9. Ghosh MB. Epistaxis with multiple myelomatosis. Eye Ear Nose Throat Mon 1969; 48:478-82.
10. Keay D. Total bilateral hearing loss as a complication of myeloma. J Laryngol Otol 1988;102:357-8.
11. Durden DD, Williams DW. Radiology of skull base neoplasms. Otolaryngol Clin North Am 2001;34(6):1043-64.
12. Funakubo T, Kikuchi A. A case of myeloma with facial palsy. Acta Otolaryngol 1994;511(Suppl):200-3.
13. Abemayor E, Canalis RF, Greenberg P, et al. Plasma cell tumors of the head and neck. J Otolaryngol 1988;17(7):376-81.
14. Corwin J, Lindberg RD. Solitary plasmacytoma of bone vs. extramedullary plasmacytoma and their relationship to multiple myeloma. Cancer 1979;43:1007-13.
15. Bergsagel DE, Rider WD. Plasma cell neoplasms. In: Devita VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. 2nd edition. Philadelphia: Lippincott; 1985. p. 1753-95.
16. Loh HS. A retrospective evaluation of 23 reported cases of solitary plasmacytoma of the mandible with an additional case report. Br J Oral Maxillofac Surg 1984;22:216-24.
17. Kost KM. Plasmacytomas of the larynx. J Otolaryngol 1990;19(2):141-6.
18. Kapadia SB, Desai U, Cheng VS. Extramedullary plasmacytoma of the head and neck: a clinicopathologic study of 20 cases. Medicine (Baltimore) 1982;61:317-29.
19. Fermand JP. Heavy chain diseases. Hematol Oncol Clin North Am 1999;13(6):1281-94.
20. Falk RH, Comenzo RL, Skinner M. Medical progress: the systemic amyloidoses. N Engl J Med 1997;337(13):898-909.
21. Sipe JD, Cohen AS. Amyloidosis. In: Braunwald E, Fauci A, editors. Harrison's principles of internal medicine, 2001. 15th edition. New York: McGraw Hill; 2001. p. 1974-9.
22. Cotran R, Kumar V, Robbins S, editors. Robbins' pathologic basis of disease 4th edition. Philadelphia: WB Saunders; 1989. p. 231-8.
23. Clevens RA, Esclamado RM, DelGaudio JM, et al. Amyloidoma of the neck: case report and review of the literature. Head Neck 1994;16:191-5.
24. Comenzo RL, Vosburgh E, Simms RW. Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: one year follow-up in five patients. Blood 1996;88(Suppl 1):686a.
25. Thompson LDR, Derringer GA, Wenig BM. Amyloidosis of the larynx: a clinicopathologic study of 11 cases. Mod Pathol 2000;13(5):528-35.
26. Husby G. Amyloidosis and rheumatoid arthritis. Clin Exp Rheumatol 1985;3:173-80.
27. Johner CH, Widen AH, Sahgal S. Amyloidosis of the head and neck. Trans Am Acad Ophthalmol Otolaryngol 1972;76(5):1354-5.
28. Talbot AR. Laryngeal amyloidosis. J Laryngol Otol 1990;104:147-9.
29. Lewis JE, Olsen KD, Kurtin PJ, et al. Laryngeal amyloidosis: a clinicopathologic and immunohistochemical review. Otolaryngol Head Neck Surg 1992;106(4):372-7.
30. Mitrani M, Biller HF. Laryngeal amyloidosis. Laryngoscope 1985;95:1346-7.
31. Clark JM. Localized laryngotracheobronchial amyloidosis: case report and review of the literature. Ear Nose Throat J 2001;80(9):632-6.
32. Skinner M, Anderson JJ, Sims R. Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone and colchicine versus colchicine only. Am J Med 1996;100:290-8.
33. Flick WG, Lawrence FR. Oral amyloidosis as initial symptom of multiple myeloma. Oral Surg 1980;49(1):18-20.
34. Schwartz MR. Pathology of the thyroid and parathyroid glands. Otolaryngol Clin North Am 1990;23:175-215.
35. Garrett JA. Amyloid deposits in the nose and maxillary sinuses. Arch Otolaryngol 1968;87:103-4.
36. El-Sayed I, Busaba NY, Faquin WC. Otologic manifestations of amyloidosis. Otol Neurotol 2002;23(2):158-9.
37. Gean-Marton AD, Kirsch CFE, Vezina LG, et al. Focal amyloidosis of the head and neck: evaluation with CT and MR imaging. Radiology 1991;181:521-5.
38. Asaumi J, Yanagi Y, Hisatomi M, et al. CT and MR imaging of localized amyloidosis. Eur J Radiol 2001;39(2):83-7.
39. Lesserson J, Finn D. Endoscopic treatment of amyloidosis of the nasopharynx. Am J Rhinol 1995;9:43-7.